Julia Robinson is our clinical and science editor.
Less than half of patients (47%) were asked for their consent before being switched to an adalimumab biosimilar, according to the preliminary results of a patient survey carried out by the National Ankylosing Spondylitis Society.
Category M reimbursement prices are to increase by £15m a month from August 2019, the Pharmaceutical Services Negotiating Committee has announced following discussions with the Department of Health and Social Care.
GP antibiotic prescribing decreases slower in older patients and those without indication, study finds
Antibiotic prescribing by GPs declined consistently between 2014 and 2017, but the rate of decline was lower in patients over the age of 55 years old, a study published in BMJ Open has found.
Recent blog posts
In 2018, our most popular research briefings covered new areas of research that have been particularly topical this year — including medical cannabis, new antibiotics and e-cigarettes — as well as areas that have long been of interest to pharmacists, such as pain management and adherence.
Julia Robinson summarises the pertinent themes discussed during The Pharmaceutical Journal’s Twitter chat held on Wednesday 12 December 2018.
Catch up on this year’s most read clinical trial stories, many of which cover important research into adverse effects of commonly used drugs.